The QualityStocks Daily Wednesday, March 4th, 2020

Today's Top 3 Investment Newsletters

QualityStocks (VTIQW) +52.67%

StockMarketWatch (APOP) +46.38%

SmallCapRelations (SHRM.CN) +40.43%

The QualityStocks Daily Stock List

Blue Moon Zinc Corp. (BMOOF)

NetworkNewsWire, 4-Traders, Mining.com, Junior Mining Network, MarketSmart Resources, Market Trend News, Investing News, Stockhouse, StreetWise Reports, TMXmoney, Small Cap Power, StockPulse, Morningstar, Geology for Investors, Market Screener, Stockwatch, TradingView, and Investors Hangout reported previously on Blue Moon Zinc Corp. (BMOOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Blue Moon Zinc Corp. engages in the exploration and development of mineral resource properties in the United States. At present, the Company is advancing its 100 percent-controlled Blue Moon zinc deposit that also contains copper, gold and silver. This project was a past producer and the Company plans to advance the Blue Moon project through to feasibility and permitting.

This resource is also open at depth and along strike. Prior metallurgical testing indicates up to 95 percent zinc recovery with standard flotation. Blue Moon Zinc has its corporate office in Vancouver, British Columbia. The Company’s shares trade on the OTC Markets.

The Blue Moon 43-101 Mineral Resource includes 7.8 million inferred tons at 8.07% zinc equivalent. This includes 771 million pounds of 4.95% zinc, 71 million pounds of 0.46% copper, 300,000 ounces of gold at 0.04 oz/t, and 10 million ounces of silver at 1.33 oz/t. Blue Moon Zinc signed a strategic joint venture (JV) where Platina Resources, Inc. (PGM.AX) can earn a 70% interest in the Blue Moon polymetallic zinc-gold-copper-silver project.

Pertaining to the Resource Update, the 2018 drill program included hole 78 that intersected 30 feet of massive sulphide mineralization grading 30.3% zinc, 1.7% copper, 1.67 g/t gold and 71 g/t silver for a ZnEq of 36.8%. This hole drilled into an earlier untested area (200 feet x 500 feet) within the deposit. It represents the highest grades ever encountered at the Blue Moon property. This hole confirms the presence of thick and steeply plunging massive sulphide mineralization within the Main Zone.

Blue Moon Zinc also has its Yava Property in Canada. The Yava Property is in the Mackenzie Mining District, Territory of Nunavut, about 450 kilometers northeast of Yellowknife. The Yava Property comprises one mining lease of 1,304 hectares and 16 unpatented mineral claims that in total encompass 4,449 hectares.

Last month, Blue Moon Zinc announced that its exploration partner, Platina Resources, confirmed significant intersections of high-grade zinc, gold and silver mineralization from the second hole completed in 2019 at its Blue Moon zinc-copper-gold project. Diamond drill hole BMZ80 intersected three significant intervals, in the form of sphalerite, chalcopyrite, galena, and minor tetrahedrite and bornite (true width is roughly 55%).

Currently, Platina Resources is paying 100% of the drill program costs. Platina can earn an initial 50% interest in the Blue Moon project through incurring $3 million including the drilling of a minimum 10,000 meters and payment to Blue Moon Zinc of $250,000. Platina can increase its interests to 70% through incurring an additional $3.75 million including the completion of a pre-feasibility study and payment to Blue Moon Zinc of $500,000.

Blue Moon Zinc Corp. (BMOOF), closed Wednesday's trading session at $0.0171, even for the day, on 1,000 volume. The average volume for the last 3 months is 3,678 and the stock's 52-week low/high is $0.009999999/$0.035999998.

chart

Concierge Technologies, Inc. (CNCG)

Stock Gumshoe, Speculating Stocks, Wallet Investor, Digital Journal, Real Investment Advice, Trading View, Stockopedia, Investors Guide, Stock News Now, Business Wire, Equity Clock, Investor Point, Market Exclusive, Market Wire News, GlobeNewswire, MarketBeat, Stockhouse, Investors Hangout, Wallmine and Market Screener reported beforehand on Concierge Technologies, Inc. (CNCG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Concierge Technologies, Inc. is an international holding firm, with operating subsidiaries in financial services, food manufacturing, security systems and beauty products. The Company’s offices and manufacturing operations are in the United States, New Zealand and Canada. Concierge Technologies’ aim is to acquire other diverse companies that are established, profitable, have in-place management teams, sustainable business models and can be purchased for a fair price. Concierge Technologies is headquartered in San Clemente, California.

The OTCQB-listed, Company’s subsidiaries include Brigadier Security Systems, Ltd. (Saskatoon, Saskatchewan); Gourmet Foods, Ltd. (Tauranga, New Zealand); Original Sprout; and USCF (Walnut Creek, California). Concierge Technologies, via its subsidiaries, produces, packs, and distributes meat pies and related bakery confections to the groceries, gasoline convenience stores, and independent retailers in the United States, New Zealand, and Canada. In addition, the Company engages in the provision of security alarm system installation and monitoring services; and the wholesale distribution of hair and skin care products under the brand name Original Sprout.

Brigadier Security Systems provides comprehensive security solutions to homes and businesses, government offices, schools and other public buildings throughout the Province of Saskatchewan. Original Sprout produces and distributes a complete line of vegan, safe, non-toxic hair and skin care products, including a "reef safe" sun screen. Original Sprout products are completely non-toxic, 100 percent vegan & cruelty free, gluten & dairy free, have no petroleum oils, parabens or phytoestrogens, dioxanes, harmful sulfates, phthalates, formaldehyde & propylene glycol.

Gourmet Foods is a commercial-scale bakery. It produces and distributes iconic meat pies and pastries throughout New Zealand under the brand names Pat's Pantry and Ponsonby Pies. USCF Investments serves as manager, operator or investment adviser to 13 exchange traded products, structured as limited partnerships or investment trusts that issue shares trading on the NYSE Arca.

Last week, Concierge Technologies announced the creation of Marygold & Co. This is a new operating subsidiary that offers individuals and their families a secure way to send, receive, spend and save via its mobile platform. Launching this year, Marygold & Co. is bringing private banking solutions previously limited to the wealthy directly into the hands of everyday consumers, with no credit-checks and no minimum balances.

Mr. Nicholas Gerber, Chairman and Chief Executive Officer of Concierge Technologies, said, "Today's news builds upon Concierge Technologies' roadmap to expand its financial services business, led by USCF Investments, our company's largest holding. We are very excited at the opportunity of expanding into fintech, as the market potential for safe and secure mobile banking continues to grow among consumers."

Concierge Technologies’ wholly owned subsidiary, Original Sprout, will be exhibiting at the Natural Products Expo West at the Anaheim Convention Center in Anaheim, California, March 5-7, 2020.

Concierge Technologies, Inc. (CNCG), closed Wednesday's trading session at $1.87, even for the day, on 4 volume with 1 trade. The average volume for the last 3 months is 294 and the stock's 52-week low/high is $0.654044985/$2.00.

chart

FEC Resources, Inc. (FECOF)

Zacks, Pink Investing, hot Stocked, Investors Village, Street Insider, last10k, Nasdaq, MarketScreener, Morningstar, Barchart, Research and Markets, Dividend Investor, Stockopedia, Dividend.com, InvestorsHub, TipRanks, GuruFocus, EODData, YCharts, Investors Hangout, Infront Analytics, Seeking Alpha, Wallet Investor, and MacroTrends reported earlier on FEC Resources, Inc. (FECOF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

FEC Resources, Inc. engages in the acquisition, exploration, and, when warranted, development of natural resource and mineral properties. The Company is a subsidiary of PXP Energy Corporation (Philex) who holds 54.99 percent of the undiluted issued and outstanding capital of the Company. The main investment of FEC Resources is a 6.80 percent stake in the United Kingdom (UK) company Forum Energy Limited. FEC Resources has its corporate office in Vancouver, British, Columbia. The Company’s shares trade on the OTC Markets.

Forum Energy Limited's main asset is a 70 percent interest in the GSEC101 offshore licence positioned to the northwest of the Philippine island of Palawan. This area is approximately 10,360 Km2. It contains the Sampaguita gas discovery that has expected gas in place of 3.4TCF and potential upside to 20 TCF (Trillion Cubic Feet). In addition, FEC Resources has an investment in a gold exploration project in the Philippines.

This past December, FEC Resources announced that its Board of Directors approved an offering to its existing shareholders of non-transferrable rights to purchase additional common shares of the Company to raise gross proceeds of up to roughly US$1,841,147. In connection with the Rights Offering, FEC Resources filed with the U.S. Securities & Exchange Commission (SEC) a registration statement on Form F-1 and prospectus for the issuance of the Rights and Common Shares pursuant to the Rights Offering.

FEC Resources expects to use the proceeds from the Rights Offering for general working capital purposes (chiefly the payment of administrative expenses) and to provide the Company with funds for investment opportunities. This includes participation in any fund raising of Forum Energy Limited in order for FEC Resources to maintain its percentage shareholder interest in that company. FEC Resources reserves the right to terminate the Rights Offering at any time before its expiration date.

FEC Resources, Inc. (FECOF), closed Wednesday's trading session at $0.002, even for the day, on 10,000 volume. The average volume for the last 3 months is 144,254 and the stock's 52-week low/high is $0.001/$0.0135.

chart

Five Prime Therapeutics, Inc. (FPRX)

Zacks, Enterprise Echo, BioInvest, StockInvest.us, StockNews, InvestorsHub, Stocktwits, BioPharmCatalyst, FierceBiotech, Investors Observer, Street Insider, Equities.com, Markets Insider, Investing.com, Market Chameleon, Simply Wall St, Morningstar, Seeking Alpha, MacroTrends, YCharts, Dividend Investor and Nasdaq reported earlier on Five Prime Therapeutics, Inc. (FPRX), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Five Prime Therapeutics, Inc. is developing novel immuno-oncology protein therapeutics. The Company is working to develop immune modulators and precision therapies for solid tumor cancers. Its product candidates have unique mechanisms of action and address patient populations in need of better therapies. A clinical-stage biotechnology company, Five Prime Therapeutics has its head office in South San Francisco, California. The Company lists on Nasdaq.

Five Prime concentrates on researching and developing immuno-oncology and targeted cancer therapies paired with companion diagnostics to identify patients who are most likely to benefit from treatment with the Company’s product candidates. Five Prime Therapeutics has entered into strategic collaborations with top international pharmaceutical companies. The Company has promising product candidates in clinical and preclinical development.

Five Prime Therapeutics programs include Bemarituzumab - FGFR2B Antibody - FIGHT trial (with chemo) in 1L gastric/GEJ cancer; and FPA150 B7-H4 Antibody - Breast, ovarian and endometrial cancers. Programs also include FPT155 - CD80-FC Fusion - Multiple tumor settings; and I-O Antibodies - Multiple tumor settings.

Bemarituzumab (anti-FGFR2b) is a first-in-class isoform-selective antibody with enhanced antibody-dependent cell-mediated cytotoxicity (ADCC) in development as a targeted immunotherapy for tumors that overexpress FGFR2b. Bemarituzumab is undergoing evaluation in combination with mFOLFOX6 in the Phase 3 FIGHT (FGFR2b Inhibition in Gastric and Gastroesophageal Junction Cancer Treatment) trial. Five Prime Therapeutics has paused enrollment in the FIGHT trial pending the occurrence of a sufficient number of events to trigger a futility analysis, expected to occur in mid-2020.

In February 2020, Five Prime announced a worldwide license agreement with Seattle Genetics, Inc. This is to develop and commercialize novel ADC therapies using monoclonal antibodies developed by Five Prime that are directed to a single target. With this agreement, Five Prime received a $5 million upfront payment. The Company is eligible to receive progress-dependent development and regulatory milestone payments and also cumulative commercial milestone payments. Cumulative milestone payments may reach up to $525 million for the first two ADC product candidates.

Mr. William Ringo, interim Chief Executive Officer and Chairman of the Board, said last week, “Our 2020 focus is on generating clinical data from three proprietary programs that will allow us to prioritize future pipeline investments. Additionally, we are advancing our novel late-stage research programs and plan to bring one new program into preclinical development later this year. We are also looking to acquire early-stage clinical assets that we can develop to generate actionable data in the near- to medium-term by utilizing our clinical development and translational expertise.”

Five Prime Therapeutics, Inc. (FPRX), closed Wednesday's trading session at $3.84, off by 5.4187%, on 264,297 volume with 2,497 trades. The average volume for the last 3 months is 497,781 and the stock's 52-week low/high is $3.18000006/$13.8400001.

chart

Pilot Bancshares, Inc. (PLBN)

OTC Markets, Penny Stock Hub, Street Insider, TipRanks, YCharts, PR Newswire, Nasdaq, GuruFocus, Wallet Investor, TradingView, Dividend Investor, Stockopedia, Barchart, Dividend.com, Market Screener, Investors Hangout, Biz Journals, dividata, Morningstar and Seeking Alpha reported previously on Pilot Bancshares, Inc. (PLBN), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Pilot Bancshares, Inc. operates as the bank holding company for Pilot Bank. The Bank provides retail, commercial, as well as investment services to individuals, businesses, and institutions in the greater Tampa Bay and Lakeland, Florida areas. Pilot Bank was Chartered by the State of Florida in 1987. The Bank’s holding company, Pilot Bancshares, Inc. was formed in October 1995. A Florida corporation, Pilot Bancshares is headquartered in Tampa, Florida. The Company lists on the OTC Markets Group’s OTCQX. Pilot Bank holds a five-star Bauer rating.

Pilot Bancshares’ primary holdings are National Aircraft Finance Company (NAFCO) and the aforementioned Pilot Bank, a state-chartered commercial bank and member of the Federal Reserve System. NAFCO specializes in the origination of owner-flown aircraft loans, most of which are purchased by Pilot Bank.

Pilot Bank’s six financial centers in Tampa Bay are strategically located in South Tampa, New Tampa, Temple Terrace, Upper Tampa Bay, and St. Petersburg. A sixth financial center is located in the Lakeland business district.

The design of Pilot’s complete family of financial products and services is to help customers manage personal and business matters as conveniently as possible. Pilot Bank offers retail and commercial deposit accounts and wide-ranging commercial lending capabilities (including Small Business Administration Loans), and also access to professional investment services.

Personal Banking Services include Personal Checking Accounts, Savings Accounts, Money Market Accounts, and Certificates of Deposit, and Remote Deposits. Furthermore, Personal Banking Services include Personal Online Banking, Health Savings Accounts, and Consumer Loans.

Pilot Bank also offers home equity and consumer loans; commercial real estate mortgages, term loans, equipment financing, working capital lines of credit, small business administration loans, and business credit cards. Moreover, the Bank offers construction and permanent financing for income producing properties, and lines of credit for builders. Pilot also provides treasury management and merchant services; aircraft financing; investment services, and online banking services.

Pilot Bancshares, Inc., the parent company of Pilot Bank, reported consolidated total assets as of December 31, 2019 of $431.1MM. This represents an increase of $4.38MM from September 30, 2019, or 1 percent.

Compared to December 31, 2018, total assets grew $69.76MM, or 19.3 percent. Gross loans for the full year ended at $345.57MM. This represents quarterly growth of $4.96MM or 1.5 percent and year-over-year growth of $55.49MM, or 19.13 percent. Total deposits for December 31 were $358.24MM. This represents an increase of $10.13MM or 2.9 percent from the prior quarter and $66.93MM, or 22.98 percent from the same period one year before. Total equity capital was $43.3MM, up $2.36MM or 5.7 percent from December 2018.

Pilot Bancshares, Inc. (PLBN), closed Wednesday's trading session at $3.63, even for the day, on 4,200 volume. The average volume for the last 3 months is 4,068 and the stock's 52-week low/high is $3.22000002/$3.70000004.

chart

Polarean Imaging Ltd. (PLLWF)

OTC Markets, Nasdaq, Barchart, 4-Traders, Market Screener, TradingView and Morningstar reported previously on Polarean Imaging Ltd. (PLLWF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Polarean Imaging Ltd. designs and manufactures equipment for the production of hyperpolarized xenon or helium gas. The Company’s team has a combined 50 years of experience in the design, development, production and service of hyperpolarized equipment. A clinical-stage enterprise, Polarean Imaging’s core technology is a drug-device combination product that enables the visualisation of hyperpolarised 129Xe (HPX) using MRI technology to help diagnose lung disease earlier, identify the kind of intervention likely to benefit a patient, and to monitor the efficacy of treatment. Polarean Imaging is based in the Research Triangle Park area of North Carolina (Durham).

The Company launched in January 2012 after securing all of GE Healthcare’s assets in the field of hyperpolarized gas MRI. This includes the exclusive rights to roughly 30 patent families. At present, Polarean Imaging’s technology is for investigational use only. The Company is pursuing regulatory approval for clinical use. In addition, it sells its hyperpolarizers and related equipment to academic research institutions around the world.

Polarean Imaging systems are installed at academic research institutions internationally, including the United States, Canada, the United Kingdom, Germany, and Sweden. Further to providing academic researchers with this equipment and support, the Company. offers access to the intellectual property (IP) that provides freedom-to-operate in this technology area.

Hyperpolarization of 129Xe is accomplished through placing a non-radioactive isotope of the Xenon source gas into a beam of polarized laser light in the presence of very small amounts of an alkali metal. The result is Xenon, whose nuclear magnetic spin is highly aligned, but not chemically or biologically different than un-polarized Xenon, a harmless inert gas.

Upon the Xenon being hyperpolarized, it can be dispensed in a plastic bag, the amount of polarized gas is verified and then it is administered to the subject already lying down inside the MRI scanner. The patient inhales a small quantity (a few hundred ml) of the gas and undergoes a MRI scan. The MRI scan is usually completed within a 10-20 second breath hold.

This past January, Polarean Imaging announced positive top-line results from two pivotal Phase III clinical trials of its drug-device combination that uses hyperpolarized 129Xenon gas MRI to visualize and quantify regional lung function. The drug, 129Xenon, when polarized in the Company’s proprietary system, permits functional, regional and quantitative imaging of the lungs using MRI, without the use of ionizing radiation.

Mr. Richard Hullihen, Chief Executive Officer of Polarean Imaging, said, “The positive results of these clinical trials validate our belief that Polarean’s technology allows clinicians to visualize aspects of lung function, which have never before been visible by MRI, both safely and quantitatively… Given the limitations of existing methods to diagnose and monitor lung disease, we see a significant unmet need for non-invasive, quantitative and cost-effective image-based diagnosis technology without exposing patients to ionizing radiation. We believe that our technology has the potential to overcome these limitations and we look forward to using data from the clinical trials to support our New Drug Application.”

Polarean Imaging Ltd. (PLLWF), closed Wednesday's trading session at $0.35, off by 7.8947%, on 701 volume with 1 trade. The average volume for the last 3 months is 23 and the stock's 52-week low/high is $0.219999998/$0.379999995.

chart

Smith-Midland Corporation (SMID)

Zacks, StockInvest.us, ValueWalk, TradingView, Wallet Investor, Nasdaq, GlobeNewswire, Simply Wall St, MarketBeat, Funding Universe, GEO Investing, TipRanks, Market Screener, Tech Capital, Investing.com, 4-Traders, Wallet Investor, Corporate Information, GuruFocus, last10k, Stockopedia, TMXmoney, Stockhouse and InvestorsHub reported earlier on Smith-Midland Corporation (SMID), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Smith-Midland Corporation develops, manufactures, and sells a wide assortment of precast concrete products for use chiefly in the construction, transportation, and utilities industries. The Company has three manufacturing facilities located in Midland, Virginia; Reidsville, North Carolina; and Columbia, South Carolina. Established in 1960, Smith-Midland is based in Midland, Virginia. The Company lists on the OTC Markets Group’s OTCQX.

Easi-Set Worldwide is a wholly-owned subsidiary of Smith-Midland Corporation. Easi-Set Worldwide licenses the production and sale of Easi-Set products, including J-J Hooks, and provides diversification opportunities to the precast industry internationally.

Additionally, Concrete Safety Systems (CSS) is Smith-Midland’s safety barrier rental division. CSS is supplied by Smith-Midland’s three production facilities. CSS provides concrete safety barrier rental for highway construction and other projects across its mid-Atlantic and Southeast market area. CSS serves its regional clients via a network of seven rental yards.

J-J Hooks is the most popular barrier connection design in North America. It continues to play a leadership role in safety innovation for the highway construction industry. Greater than 15,000,000 linear feet of J-J Hooks temporary barrier have been produced and installed globally since its introduction in 1990.

Smith-Midland’s manufacturing plants include steel shops, form fabrication shops, automated concrete batch plants, and environmentally controlled casting areas. Among the Company’s major innovations are J-J Hooks positive connection safety barriers; SoftSound, a sound absorbing concrete for highway sound barrier; and Easi-Set/Easi-Span Precast Buildings with post-tensioned roofs & floors. Furthermore, major innovations include SlenderWall architectural building panels and Beach Prisms Shoreline erosion control product.

Smith-Midland's new North Carolina precast concrete plant, Smith-Carolina, has opened for business. The 15,000 square foot enclosed plant sits on a 46 acre yard at 654 Freeway Drive in Reidsville, North Carolina. It allows plenty of room for future expansions. New features include a large capacity 4-yard concrete batch plant, and two 20-ton overhead bridge cranes. Initial production started on high-demand products such as the market leading J-J Hooks precast concrete highway barrier.

This past January, Easi-Set Worldwide announced the addition of Summit Precast, LLC to its family of J-J Hooks precast concrete safety barrier licensed producers, North America's most successful licensed barrier design. Based in Montgomery, Texas, Summit Precast is owned by the Ogorchock family. The Ogorchock's have years of prior precast concrete barrier manufacturing experience.

Easi-Set Worldwide will be exhibiting at The Precast Show March 5-7, 2020 in Fort Worth, Texas. The Precast Show is sponsored by the National Precast Concrete Association and the Precast/Prestressed Concrete Institute with additional collaboration from the Canadian Precast/Prestressed Concrete Institute and the Cast Stone Institute.

Smith-Midland Corporation (SMID), closed Wednesday's trading session at $5.70, off by 5.7851%, on 10,151 volume with 20 trades. The average volume for the last 3 months is 12,375 and the stock's 52-week low/high is $5.3499999/$9.52999973.

chart

Durango Resources, Inc. (ATOXF)

OTC Markets, MarketWatch, Barchart, Wallet Investor, High Rising Stocks, OTC Stock Watch, Resource World, Penny Stock Hub, Stockhouse, InvestorX, Investors Guru, Stockwatch, and Jet Life Penny Stocks reported earlier on Durango Resources, Inc. (ATOXF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Durango Resources, Inc. acquires and explores for precious and base mineral properties in Canada. The Company has a large asset pool of claims. It has projects in strategic areas adjoining Osisko, Nemaska Lithium, Lakeshore Gold, GT Gold, and Garibaldi Resources. Incorporated in 2006, Durango Resources has its corporate headquarters in Vancouver, British Columbia. The Company’s common shares commenced trading on the OTCQB® Venture Market in the U.S. under the symbol “ATOXF” on March 13, 2018.

Durango Resources has 100 percent owned Canadian properties. The Company’s properties include Dianna Lake, Saskatchewan; Whitney Northwest, Ontario; NMX East, Quebec; Decouverte (Discovery), Quebec; Mayner’s Fortune, British Columbia; Windfall Lake Properties, Quebec; and Buckshot Graphite, Quebec.

The Decouverte Property in James Bay, Quebec had an independent technical review completed as reported on January 16, 2018. The review supports a drilling program of 3,800 meters across 36 holes. Decouverte is a grassroots gold project. It is targeting greenstone-hosted orogenic gold mineralization. The Decouverte property is 57 square kilometers (5,700 ha). Six target areas are defined on the property. Each of these ranges from 100 meters to 400 meters along strike.

Durango Resources will continue to hold 100 percent interest in its Trove Property in Québec. The Trove Property is 1,188 hectares in size. It is among the Windfall Lake gold deposit - one of the highest-grade resource stage gold projects in Canada. The Trove claims are in the Windfall-Urban Gold Camp district of northern Québec surrounded by properties held by Osisko Mining, Inc. and are a direct extension of the southwest mineralized trend that BonTerra Resources, Inc. is exploring on its Gladiator Gold Deposit and Coliseum Gold property.

Durango Resources announced in 2018 that it entered into a property purchase agreement to acquire an additional 2,358 hectares in Windfall Lake, Québec. The Property is in a key position of the Urban-Barry Greenstone belt of Québec. It is positioned approximately 5.5km south of Osisko Mining’s Black Dog Project, and roughly 10km south of the Barry Gold Deposit, now owned by BonTerra Resources.

This past December, Durango Resources announced that an airborne survey conducted on its wholly-owned Trove property in the Windfall Lake Urban Barry region of Quebec outlined a magnetic anomaly. An airborne survey was completed by BonTerra Resources while the property was under option to BonTerra in 2018. The survey shows an anomaly following the regional fault that trends through the property.

Also, in December, Durango Resources reported that further to its news of November 2, 2018, the Company received further positive assay results on the additional till samples taken on the East claim block at Windfall Lake, Québec. Nine additional till samples were obtained down strike along the same gold trend where earlier gold grains were discovered on the East block of claims. Each of the samples submitted for gold grain count and fire assay have once again all returned visible gold grains extending the earlier known 5km trend to roughly 10km.

Durango Resources, Inc. (ATOXF), closed Wednesday's trading session at $0.05, up 43.6782%, on 210,000 volume with 17 trades. The average volume for the last 3 months is 1,504 and the stock's 52-week low/high is $0.029999999/$0.062799997.

chart

Petro River Oil Corp. (PTRC)

Market News Updates, Real Investment Advice, The Street, Corporate Information, Simply Wall St, Oil Voice, Wolf Street, OTC Stock Review, InvestorsHub, MarketWatch, Streetwise Reports, The Energy Report, Stockhouse, Wallet Investor, GuruFocus, Market Screener, Morningstar, 4-Traders, and YCharts reported earlier on Petro River Oil Corp. (PTRC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Petro River Oil Corp. utilizes 3D seismic technology to discover and develop oil and gas reserves in proven oil and gas basins. The Company’s core acreage is positioned in Osage County, Oklahoma. Petro River Oil owns a 14.52 percent equity interest in Horizon Energy Partners, LLC. Additionally, its President, Mr. Stephen Brunner, is a member of the Board of Managers of Horizon Energy Partners, LLC. An independent oil and gas exploration company, Petro River Oil is based in New York, New York. The Company also has an office in Kingwood, Texas.

Petro River Oil’s Management team has drilled more than 800-plus successful wells in the vicinity of the Company’s 87,754 acre Pearsonia West Lease Concession in Osage County, Oklahoma. Management’s historic success rate in the area is 90 percent.

Petro River Oil’s emphasis is on high rate return assets. The Company’s strategy is to apply modern technology, including 3D Seismic analysis, to exploit hydrocarbon-prone resources in historically prolific plays and underexplored prospective basins. This is to build reserves and to create value for Petro River Oil and its shareholders.

Petro River Oil has successfully drilled three additional wells and discovered two new oil fields in Osage County, Oklahoma since the end of April 2018. These are the North Blackland field and the Arsaga field. The success of the Company’s most recent exploration well, the Arsaga 25-2, was announced in July of 2018. Preliminary results indicated 30 feet of productive Mississippian Chat formation, with an estimated ultimate recovery of 50,655 barrels of oil equivalent based on the Reserve Report.

The Arsaga field is Petro River Oil’s largest oil field discovery with about 2,000 prospective acres and up to 100 well locations. With the success of the Arsaga field, and the West and North Blackland fields, the Company anticipates significant cash flow from oil and gas production this year.

At the end of July 2018, Petro River Oil announced its year end April 30, 2018 financials and 2018 guidance. Highlights include a 1,131 percent increase in oil and gas production in fiscal year 2018 from fiscal year ending April 30, 2017. Company production ramped up, with greater than 60 percent of the new production occurring in Q4.

Highlights also include a 395 percent increase in proved and probable reserves in fiscal year 2018 per the May 1, 2018 evaluation (Reserve Report) by independent engineering firm Cawley, Gillespie & Associates. Moreover, highlights include an 11.27 percent decrease in general and administrative expenses for fiscal year 2018.

Petro River Oil Corp. (PTRC), closed Wednesday's trading session at $0.129, up 84.2857%, on 44,433 volume with 29 trades. The average volume for the last 3 months is 17,777 and the stock's 52-week low/high is $0.05/$0.670000016.

chart

Alltemp, Inc. (LTMP)

MissionIR, Stock Communications Group, Dividend Investor, 4-Traders, InvestorsHub, GuruFocus, The Street, Investors Hangout, Barchart, StockInvest, MarketWatch, Stockhouse, Morningstar, Wallet Investor, Market Screener, and Capital Cube reported earlier on Alltemp, Inc. (LTMP), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Alltemp, Inc. is a developer of proprietary, environmentally-friendly, refrigerant technologies. The Company has developed a proprietary refrigerant technology, called alltemp®. This is a proven replacement for many global refrigerants that have adversely affected the worldwide environment.  Alltemp is based in Westlake Village, California.

alltemp®’s refrigerants are for the commercial and residential markets. alltemp® is the Company’s solution for the replacement of R-407c, R-134a, R-404a, and HCFC-22, known as R-22, but which is quickly being phased out in all developed nations because of environmental concerns over its strong effect on the depletion of the Earth's ozone layer.  

alltemp® refrigerants have broad applications. These range from Heating Ventilation and Air Conditioning (HVAC), to refrigeration and foam insulation, to industrial solvents. alltemp® solutions provide a sustainable, eco-friendly, true drop-in refrigerant. It meets the Montreal/Kyoto Protocols and EPA  (Environmental Protection Agency) standards with the lowest Global Warming Potential for any non-flammable HFC. alltemp®  yields a 27 percent average decrease in kWh,  without loss in capacity.

  Alltemp successfully completed two years of early adopter testing of its alltemp® refrigerant at several Fortune 100 companies' facilities for its Montreal and Kyoto Protocol compliant refrigerant. Furthermore, test results revealed that alltemp® yielded significant average savings in energy consumption. This is while maintaining capacity.

Alltemp announced in January 2018 that it released a new refrigerant alternative for R-404A applications called alltemp® 4. This is a drop-in refrigerant. R-404A has one of the highest GWPs (Global Warming Potential) of any HFC refrigerants. It is quickly being phased out in the European Union (EU) and other developed countries.

Alltemp announced in March 2018 that flashpoint chamber testing conducted by DEKRA Insight confirmed that alltemp® refrigerant has zero flammability. A minimum of 20 different chamber tests in the liquid phase and 20 vapor phase tests, with temperatures as high as 60º C = 140º F, revealed zero flammability and no ignition with alltemp® refrigerant.

Alltemp has its R-410A replacement refrigerant, designated alltemp® H. Like the Company’s other refrigerants, alltemp® H is engineered to use the same anti-corrosive and non-flammable alltemp® core technology that provides major energy efficiencies and meets ASHRAE A1 safety classification standards.

R-410A was designed to replace R-22, which has a substantial environmental impact and Ozone Depletion Potential (ODP). The lower the GWP value, the better the refrigerant is for the environment. R-410A has a Global Warming Potential (GWP) rating of 2,088. Its predecessor R-22 has a GWP rating of 1700.

Alltemp, Inc. (LTMP), closed Wednesday's trading session at $0.0325, up 41.3043%, on 1,237 volume with 4 trades. The average volume for the last 3 months is 43,385 and the stock's 52-week low/high is $0.021099999/$0.090000003.

chart

Gilla, Inc. (GLLA)

Greenbackers, Zacks, GuruFocus, The Street, SmallCapVoice, SmallCapFinancialWire, StockAnalyst24, Barchart, TopPennyStockMovers, Marketbeat, StockBlogs, Dividend Investor, YCharts, and Real Pennies reported on Gilla, Inc. (GLLA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Gilla, Inc. manufactures, markets, and distributes E-liquid (the liquid used in vaporizers and E-cigarettes) and other vaping hardware and accessories. The Company’s objective is to be a global leader in delivering the most efficient and effective vaping solutions for nicotine and cannabis related products. In addition, Gilla is a developer of cannabis concentrate products. The Company is based in in Toronto, Ontario. Gilla’s manufacturing facility is in Daytona Beach, Florida.

The Company’s proprietary product portfolio includes Spectrum Concentrates, Coil Glaze™, Craft Vapes™, Siren, The Drip Factory, Shake It, Surf Sauce, Ohana, Moshi, Crisp, Just Fruit, Cassidy's Outlaw Series, Vinto Vape, Vapor's Dozen, Enriched Vapor, and Crown E-liquid™.

Gilla announced in May 2018 its plan to pursue a spin-off of its cannabis-related business to the Company’s shareholders. The expectation is that the transaction will result in two separate public companies that will benefit from separating their respective corporate strategies and capital allocation priorities.

Gilla announced this past July that it entered into a Letter of Intent (LOI) to acquire all of the issued and outstanding shares of TB INVEST BVBA. TB Invest is a Belgium-based distributor and retailer of E-liquid and other vapor products.

The acquisition of TB INVEST would be a transformative acquisition for Gilla creating a vertically integrated business amalgamating Gilla's international manufacturing platform with TB Invest's European-centered distribution and retail business.

Recently, Gilla provided an update on the Company’s earlier announced Letter of Intent (LOI) to acquire all of the issued and outstanding shares of TB Invest BVBA. Gilla along with TB Invest are advancing the definitive agreements. They are working with their respective advisors to structure the transaction in accordance with the requisite regulations and on substantially the same terms as described in the press release dated July 16, 2018. There have been no material changes to the transaction as contemplated in the LOI. Gilla and TB Invest are working diligently to close the transaction before the calendar year end.

Gilla, Inc. (GLLA), closed Wednesday's trading session at $0.006, up 41.1765%, on 73,200 volume with 2 trades. The average volume for the last 3 months is 15,281 and the stock's 52-week low/high is $0.0013/$0.064999997.

chart

Nickel Creek Platinum Corp. (NCPCF)

InvestorsHub, InvestorX, The Frugal Forager, Northern Miner, Stockhouse, Metals News, Business Insider, OTC Markets, Investors Hangout, Wallmine, and Portfolio Sharing reported earlier on Nickel Creek Platinum Corp. (NCPCF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Nickel Creek Platinum Corp. is a mining exploration and development company headquartered in Toronto, Ontario. Its focus is on advancing its 100 percent-owned Nickel Shäw Project with the aim of creating Canada's next world-class nickel sulphide mine. The Company previously went by the name Wellgreen Platinum Ltd. It changed its corporate name to Nickel Creek Platinum Corp. in January of this year. Nickel Creek Platinum lists on the OTC Markets Group’s OTCQX.

The 100 percent-owned Nickel Shäw project is positioned in the southwest of Canada’s Yukon Territory, around 317 km northwest of the capital, Whitehorse. The Project has excellent access to infrastructure, located three hours west of Whitehorse via the paved Alaska Highway, which further provides year-round access to deep-sea shipping ports in southern Alaska.

Nickel Shäw is host to more than 2 billion pounds of nickel, 1 billion pounds of copper, 6 million ounces of platinum group metals (PGM's) and 120 million pounds of cobalt in the Measured and Indicated categories. The Nickel Shäw Property lies within the Kluane First Nation core area as defined by their treaty with Canada and the Yukon Government.

Nickel Creek Platinum reported this past July the final results of its Phase II Metallurgical Program on the Nickel Shäw Project. The Phase II Metallurgical Program succeeded in its primary objective of separating bulk CuNi concentrate into separate saleable nickel and copper concentrates. This represents the most in-depth and comprehensive metallurgical undertaking completed so far at the Project.

Recently, Nickel Creek Platinum announced an update on the status of its Nickel Shäw Project. Following the conclusion of the Company’s Phase II Metallurgical Program, it embarked on more work toward completing a Preliminary Economic Assessment (PEA). During the course of the Phase II Metallurgical Program, it reported that it identified a strong correlation between nickel recovery and total sulphide content.

Particularly, it was determined that the presence of sulphides (sulphur in pyrrhotite) was an important marker of nickel recovery. This means that the areas of higher sulphur yielded higher recoveries, and areas of lower sulphur yielded lower recoveries, irrespective of nickel head grade, which remains relatively consistent throughout the deposit.

Nickel Creek Platinum Corp. (NCPCF), closed Wednesday's trading session at $0.08, up 56.3722%, on 45,708 volume with 7 trades. The average volume for the last 3 months is 101,706 and the stock's 52-week low/high is $0.018999999/$0.103.

chart

ULURU, Inc. (ULUR)

Equity Clock, OTC Markets, Innovative Marketing, The Street, Market Screener, GuruFocus, MarketWatch, SmallCapVoice, Zacks, Marketbeat, BabyBulls, Endocrinology Advisor, and TopPennyStockMovers reported earlier on ULURU, Inc. (ULUR), and today we report on the Company, here at the QualityStocks Daily Newsletter.

ULURU, Inc. is a specialty pharmaceutical company headquartered in Addison, Texas. It is focusing on the development of a portfolio of wound management and oral care products. This is to provide patients and consumers improved clinical outcomes through controlled delivery using the Company’s innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system.  ULURU lists on the OTC Markets Group’s OTCQB. 

  ULURU’s strategy is to develop and commercialize a customer-focused portfolio of unique wound care products to treat the different phases of wound healing. In addition, the Company’s strategy involves developing the oral-transmucosal technology and generating revenues via manifold licensing agreements.

ULURU’s Nanoflex® Technology is a new class of material. The design of it is to optimize the wound bed environment and accelerate healing. The Company has its Altrazeal® product.  It developed and commercializes Altrazeal® - a transforming powder dressing with proprietary Nanoflex® technology, for the management of exuding wounds. Altrazeal® is a scientifically engineered advanced wound dressing designed to incorporate the desired features and benefits of the ideal wound dressing.

Altrazeal® is produced as a sterile powder and is unique in application and performance on a moist wound surface. Upon application to a moist wound, the powder interacts with wound exudate and hydrates. Hydration with exudate causes the powder to aggregate irreversibly and form a moist wound dressing that conforms to the surface of a wound bed and seals the wound.  Altrazeal® has demonstrated potential clinical and economic advantages in numerous chronic and acute wounds.

ULURU has its patented delivery strip for whitening teeth, which completely erodes - the OraDisc™ W- Erodible Whitening Strip for Teeth. This proprietary tooth whitening product comprises a laminated bilayer strip that uses OraDisc™ technology. 

Additionally, the Company has its OraDisc™A product. ULURU developed OraDisc™ A, a novel mucoadhesive, water-erodible disc incorporating 2mg of amlexanox, for the treatment and prevention of aphthous ulcers. Moreover, the Company’s OraDisc™ B is a mucoadhesive erodible disc containing 15 mg of benzocaine. It was developed for the treatment of oral pain.

ULURU, Inc. (ULUR), closed Wednesday's trading session at $0.025, up 40.4494%, on 500 volume with 1 trade. The average volume for the last 3 months is 20,404 and the stock's 52-week low/high is $0.010999999/$0.054000001.

chart

Omagine, Inc. (OMAG)

SmallCapVoice, Information Solutions Group, Agoracom, BUYINS.NET, PennyStocks24, and OnTheMar reported earlier on Omagine, Inc. (OMAG), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Omagine, Inc. conducts all its real-estate development, tourism, and entertainment business activities through either its 60 percent owned subsidiary Omagine LLC or its 100 percent owned subsidiary Journey of Light, Inc. OTCQB-listed, Omagine’s concentration is on real-estate, entertainment, and hospitality opportunities in the Middle East and North Africa (MENA Region).

Incorporated in 2004, Omagine is based in New York, New York. It has a subsidiary in Muscat, Oman. The Company’s intention is to open branch offices in Beirut, Lebanon and in Dubai, The United Arab Emirates (UAE) during 2018.

Omagine announced in October 2014 that Omagine LLC signed a Development Agreement (DA) with the Government of the Sultanate of Oman. Omagine organized Omagine LLC under the laws of Oman to design, develop, own, and operate a tourism and real-estate development project in Oman named the Omagine Project.

Omagine LLC owns the Omagine Project. The other Omagine LLC shareholders are the office of Royal Court Affairs (RCA), which owns 25 percent, and two subsidiaries of Consolidated Contractors International Company, SAL (CCIC), which jointly own 15 percent.

As well as the Omagine Project in Oman, the Company has been having discussions with Omani government officials regarding other projects in Oman. Omagine has held initial discussions with government officials and business people in the MENA region concerning comparable projects and other business opportunities there.

Omagine announced in July of 2016 that its subsidiary, Omagine LLC, signed and registered with the Government of Oman, a Usufruct Agreement (UA), which legally perfects Omagine's ownership of the development rights (the Usufruct Rights) over 245 acres of beachfront land in the Sultanate of Oman.

The Omagine Project will be a union of cultural, heritage, educational, entertainment, and residential components. This includes a high culture theme park containing seven pearl shaped buildings, associated exhibition buildings, a boardwalk, an open-air amphitheater and stage, and open space green areas.

Additionally, the Project includes commercial office buildings, shopping and retail establishments integrated with the hotels, and around 2000 residences to undergo development for sale. Moreover, it includes a canal and an enclosed harbor and marina area, associated retail shops and restaurants, entertainment venues, boat slips, and docking facilities. It also includes a five-star resort hotel, a four-star resort hotel, and conceivably a three or four-star hotel.

Currently, Omagine focuses most of its efforts on the business of Omagine LLC and particularly on the Omagine Project. The Omagine Project is a mixed-use tourism and residential real estate project. The expectation is that it will take roughly five years from the start date to complete.

Omagine, Inc. (OMAG), closed Wednesday's trading session at $0.0094, up 46.875%, on 10,125 volume with 3 trades. The average volume for the last 3 months is 18,452 and the stock's 52-week low/high is $0.002/$0.043795.

chart

The QualityStocks Company Corner

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a digital marketing and consumer-data-management technology company, is well positioned as a rising number of consumers are demanding that their data be kept private. To view the full article, visit http://nnw.fm/5b73S

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Wednesday's trading session at $2.70, up 6.2992%, on 56,698 volume with 445 trades. The average volume for the last 3 months is 97,445 and the stock's 52-week low/high is $1.04999995/$5.8499999.

Recent News

chart

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience Corp. (OTCQX:LXRP) (CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has successfully processed its first DehydraTECHTM-enabled liquid nanoemulsion for cannabidiol ("CBD") beverages for one of its licensed clients. Lexaria's client expects to begin distribution of its line of CBD beverages in select US stores soon. Also today, the company was highlighted in a publication from CBDWire, examining how the CBD sector is probably the fastest growing industry out there. Driven by immense demand due to CBD’s wide-ranging medical abilities, the industry has achieved millions of dollars in sales despite being just a year old. One of CBD’s most appealing traits is that it can be taken in several ways, and this has allowed firms to create and sell a diverse range of cannabidiol infused products.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Wednesday's trading session at $0.43, up 10.3696%, on 127,026 volume with 77 trades. The average volume for the last 3 months is 102,944 and the stock's 52-week low/high is $0.3037/$1.39999997.

Recent News

chart

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF)

The QualityStocks Daily Newsletter would like to spotlight Exro Technologies Inc. (OTCQB: EXROF).

Exro Technologies (CSE: XRO) (OTCQB: EXROF) today announced it will be presenting at the third annual LD Micro Virtual Conference at 2:40 PM EST on Wednesday, March 4. Exro's CEO Sue Ozdemir will give the presentation and answer questions from investors. To access the live presentation, visit http://nnw.fm/v0Fg7. To view the full press release, visit http://nnw.fm/k7Z0k.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), a Canadian technology company, is an innovative pioneer in the energy sector. Exro has developed and commercialized an electric power module (EPM) that integrates into existing motor systems to make them smarter. Exro’s patented technology optimizes existing motor performance by automatically sensing and adapting operating parameters to an optimized state, creating measurable efficiency gains, reduced mechanical components and increased system availability.

Applications

Exro’s technology and efficiency optimization algorithms improve the performance and efficiency of electric motors by manipulating power delivery to individual coils, thereby enabling the ability to expand operating parameters. This novel approach is scalable and can be utilized in most variable torque applications.

The widespread applications of Exro’s technology apply to optimizing the performance of electric vehicles, locomotive traction applications, industrial motors, and other variable torque applications that benefit from smart energy conversion.

Intellectual Property

Exro’s proprietary, patented software controls electric motor coils through individual coil switching. This introduction of intelligence into energy conversion at the level of individual coils results in expanded speed/torque capability, improved machine efficiency, reliability, safety and maintenance across a wider operating range. Exro’s advanced control algorithms create smart, real-time optimized power management.

Exro currently holds 15 patents, with 8 patents pending and additional patents under development. The company continues to expand its IP portfolio to support its goal of becoming a globally recognized leader in leveraging advanced control algorithms to improve the performance, efficiency and longevity of electric motors and generators.

Market Opportunity

Electric motors are the single biggest consumer of electricity. They account for about two-thirds of industrial power consumption and about 45% of global power consumption, according to an analysis by the International Energy Agency. Exro’s technology seeks to give industries a new way to look at energy—from electric vehicles, to industrial equipment, to renewable applications like wind farms; we are improving the way energy is consumed.

Laboratory Expansion

The 6,500-square-foot Exro Innovation Center (EIC), scheduled to open spring of 2020 in Calgary, will transition the current Victoria lab into one Calgary based center. The company’s new laboratory space will expand its service capabilities to customers, provide larger test capabilities, and showcase how Exro’s technology can be applied to dramatically improve the performance of electrical motors.

The EIC will also host collaborative events to explore advances in energy consumption and electric motor innovations, with participants from across Canada and around the world.

Strategic Partnerships

  • A strategic agreement with Finland’s Aurora Powertrains Oy, which in 2019 released an all-electric production snowmobile called the “eSled,” will see Exro’s technology added to the Aurora electric powertrain. The snowmobile sector’s economic footprint is estimated at $26 billion in the U.S., $8 billion in Canada, and $5 billion in Europe and Asia.
  • An agreement with Potencia in Mexico serving the last mile vehicle segment will integrate Exro’s custom drive and EPM module into small passenger commercial vehicles (taxis) and fleet delivery trucks
  • A licensing agreement with Motorino Electric, a leader in the Canadian electric transportation industry, will integrate Exro’s Electric Power Module technology into Motorino’s CTi electric bicycle.

Management

Chief Executive Officer Sue Ozdemir is a proven leader in the innovation and manufacturing of electric motors. She has nine years of accomplishments at General Electric, acting as CCO and the CEO of GE’s Small Industrial Motors Division, overseeing the division’s North American and international markets – ultimately building the division into a $160 million enterprise.

Chief Commercial Officer Josh Sobil is leading the seamless adoption of Exro’s growing product portfolio focused on the mobility segment and opening doors in all segments including agriculture, heavy industry, energy, construction, among others.

Executive Chairman Mark Godsy is a serial technology entrepreneur who has been involved in many top tier ventures, including two of Canada’s most successful biotech companies.

Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF), closed Wednesday's trading session at $0.33729, up 14.8417%, on 123,660 volume with 43 trades. The average volume for the last 3 months is 119,875 and the stock's 52-week low/high is $0.124389998/$0.522899985.

Recent News

chart

Champignon Brands Inc. (CSE: SHRM)

The QualityStocks Daily Newsletter would like to spotlight Champignon Brands Inc. (CSE: SHRM).

Champignon Brands Inc. (CSE: SHRM) was featured today in a publication from CannabisNewsWire, examining how the future of health may reside in mushrooms. As buzzwords like ‘organic’, ‘whole’ and ‘fresh’ abound, it’s clear that society has become increasingly passionate about seeking high-quality, nutrient-rich foods. Recently, the humble mushroom has found itself in the spotlight as a surprisingly rich source of vitamins and minerals and a filling substitute for meat. Industry leaders like Four Sigmatic – which has been featured by The New York Times, Forbes, and Business Insider, among others – are working to educate the public on mushrooms’ superfood qualities. Also today, the company was highlighted in a publication from HempWireNews, examining how, over the past few years, it’s become increasingly clear that the planet is hurting under humanity’s reign. Governments from all over the globe have started taking steps to reduce environmental pollution, and for many of them, this has included recycling non-biodegradable materials like glass and plastic or banning their use outright. Not only does this reduce the impact on the environment, but it prevents the manufacture of more of these materials when they’re recycled. Additionally, NetworkNewsWire released a report highlighting the company which examines the recent news that the widening legalization of products based on psychogenic mushrooms looks set to create a whole new strand of functional foods and medicines.

Champignon Brands Inc. (CSE: SHRM) is a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements. Dedicated to revolutionizing conventional organic teas, coffees and other consumables with the infusion of a proprietary blend of artisanal mushrooms, Champignon’s expanding portfolio is crafted with the health-conscious consumer in mind.

Headquartered in Vancouver, British Columbia, Champignon’s team aims to promote the health and wellness benefits of functional mushrooms, which are used in a wide variety of health care and pharmaceutical products.

Brands

Champignon’s mushroom-derived consumer packaged goods (CPGs) portfolio includes its flagship brand, Vitality Superteas. Each carefully curated Vitality Supertea formulation was developed with the intent of helping individuals enhance and enrich their wellbeing one cup of mushroom-infused tea at a time.

Also in the portfolio are Nourish Force Supertea, a blend of Reishi Ryobus Tea Mix; Mighty Recharge Supertea, created with Lions Mane Tropical Green Ginseng Tea Mix; and Brain Enhance Supertea, a blend of Cordycep Hibiscus and Berries Tea Mix – all of which are formulated with organic ingredients and chosen for their ability to provide unique health and performance benefits.

Champignon’s flagship e-commerce store, VitalitySuperTeas.com, takes advantage of the burgeoning craft mushroom vertical space with a selection of mushroom-infused teas and accessories.

Functional Mushroom Market

Demand for consumer products infused with the nutritional and bioactive benefits of mushrooms is fueling a global market projected to reach $34.3 billion by 2024, growing at a compound annual growth rate of 8.04% from 2019-2024 (ResearchandMarkets), with Europe seen as the fastest growth leader.

According to the market study, in highest demand are products infused with Reishi – a traditional Chinese medicine also known as the “Elixer of Life” and “Mushroom of Immortality – Lions Mane and Cordyceps, followed by other types of medicinal mushrooms.

Advances in Legalization

Legalization of psychedelics for use in medicine is gaining momentum across the United States. Denver, Colorado, and Oakland and Santa Cruz, California, have decriminalized the use of psilocybin, the psychedelic molecule found in various mushrooms, while movements for legalization are gaining ground in Oregon and Iowa, among others. Decriminalize California recently teamed up with the Beckley Foundation to replicate Oakland’s success of decriminalization throughout the state of California.

An increasing number of researchers are turning their attention toward the study of psilocybin as a means to treat otherwise untreatable illnesses. The molecule’s ability to provide landmark treatment options for depression, post-traumatic stress disorder (PTSD), migraines and addiction is gaining widespread acceptance among medical professionals, unicorn investors and accredited institutions.

Potential Applications

Historical data and new scientific studies suggest therapeutic benefits of psychedelics in many areas, including drug addiction, alcoholism, depression, migraines, smoking cessation and post-traumatic stress disorder (PTSD).

The market potential in these areas are significant. To reference just one of the above conditions, the mental health arena has been frequently neglected over the last 30 years, though new research is beginning to further reinforce that psychedelic compounds have the potential to produce more effective treatments than what is currently available.

According to the World Health Organization, 25% of the world’s populous will be afflicted by mental health and/or neurological disorders. Presently, approximately 450 million people currently suffer from such conditions, placing mental disorders among the leading causes of ill-health, productive loss and disability worldwide.

Additionally, PTSD affects approximately 2.2% of the U.S. population; 7.7 million people will have PTSD at some point in their lives. Recent published studies have demonstrated the safety and efficacy of certain psychedelics when administered in a medically supervised and monitored approach.
A renaissance in alternative medicines is emerging, and Champignon has set in motion its strategy to become a key player.

2020 Stealth IP Strategy

Champignon plans to biosynthesize psilocybin within the first three months of conducting laboratory experiments, with the objective of achieving optimized and scaled production of pharmaceutical-grade psilocybin for deployment in clinical settings. This strategy includes:

  • Alternative medicine (psilocybin) IP aggregation
  • Development of cGMP formulations of bioactive compounds extracted from plants and Fungi
  • Drafting of benchmark SOPs (Standard Operating Procedures)
  • Patient aggregation, focusing on veterans

Defining a New Asset Class: Psychedelic-Inspired Medicines

In the third quarter of 2020, Champignon – through clinical trials, a compelling IP portfolio and clinical pipeline and drug development platform – plans to advance its pursuit of treatments underpinned by psychedelic substances. This strategy is broken down into two ties:

  • Non-Hallucinogenic Medicines
    • Microdosing Psilocybin/LSD
    • MDMA, commonly known as ecstasy
  • Hallucinogenic Medicines
    • Psilocybin high dose
    • LSD high dose

Partnerships

Companies worldwide are beginning to incorporate functional mushrooms into their product offerings, taking advantage of growing consumer awareness of known health benefits of the ingredients found in mushrooms.

Champignon in November 2019 entered into a distribution partnership with Eurolife Brands Inc. (CSE: EURO), a leading global markets cannabis brand empowering the medical, recreational and CPG cannabis industry worldwide through a data-driven CBD marketplace supported by exclusive and unbiased physician-backed cannabis education and detailed consumer analytics. Under the agreement, Champignon’s branded products are integrated into Eurolife’s e-commerce platform, along with potential distribution opportunities in select brick-and-mortar retail locations in Europe.

Champignon also has an R&D/production formulation agreement with Drip Coffee Social Ltd., located in Nanaimo, British Columbia, which calls for the infusion of Champignon’s proprietary mushroom extract blend into a suite of cold brew coffee products and signature in-house formulations.

Leadership

Gareth Birdsall, CEO, Corporate Secretary and Director
Gareth Birdsall has more than seven years of experience working in diverse agricultural roles such as the cultivation of various fungi, in particular Cordycepes, Reishi, Lions Mane and Chaga. He is an attendee of the British Columbia Institute of Technology, studying marketing management and finance.

Steven Brohman, CPA, CFO
Steven Brohman has more than 10 years of experience working in a variety of roles with public and private companies. He has had extensive training in the audit of publicly traded companies on the TXS, TSX Venture Exchange and OTC markets, and serves as CFO and director of various public and private companies. Brohman has a bachelor’s degree of business administration and obtained his Chartered Professional Accountant designation.

Jerry Habuda, Director
Jerry Habuda brings to Champignon over 35 years of expertise in law enforcement and specialized units. From 1977 to 2012, he served as a police officer with the Toronto Police Department. During his tenure, he was assigned to the Major Crimes Unit, investigating robberies and home invasions. He was assigned to patrol the Toronto Community Housing projects at Jane/Finch to control drug trafficking and gun violence. Habuda was with the Warrant Unit where he tracked down and arrested wanted criminals. From 1993-1997, he was assigned to the Northwest Drug Squad on undercover and surveillance work, executing narcotic search warrants. Between 2002 and 2004, Habuda headed the Street Violence Task Force, a special unit designed to curb gun and drug violence that was terrorizing the city at the time.

Champignon Brands Inc. (CSE: SHRM), closed Wednesday's trading session at $0.33, up 40.43%, on 3,879,282 volume with 837 trades. The stock's 52-week low/high is $0.235/$0.345.

Recent News

chart

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)

The QualityStocks Daily Newsletter would like to spotlight Bolt Metals Corp. (OTCQB: PCRCF).

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 40+ brands in the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities.

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade battery metals deposits within the Asia-Pacific region, employing a vertically integrated “minerals-to-market” strategy to leverage these assets to their fullest.

Bolt Metals Corp. is advancing its flagship, 100% controlled Cyclops Nickel-Cobalt located in Papua Province, Indonesia with a mandate to become a key contributor to Asia-Pacific’s rapidly expanding electric vehicle and battery supply chain.

The Cyclops project, uniquely positioned within the world’s largest producer of nickel and in proximity to China, the world’s largest “Gigafactory”, features near surface, strong nickel-cobalt mineralization. The property is situated in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Bolt Metals well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.

Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to nickel-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.

Indonesia has recently approved environmental impact studies for factories to produce battery-grade nickel chemicals in Morowali. The approval will allow investors, such as China’s stainless steel giant Tsingshan Group, to continue the construction of their high-pressure acid leaching plants in Morowali, Central Sulawesi.

Ranjeet Sundher, chief executive officer of Bolt Metals, said: “Indonesia continues to make significant strategic decisions, and this latest announcement represents an important step in Bolt Metals’s efforts to benefit from Indonesia’s rapid development as a leading market for all stages of the EV supply chain. With offices in Vancouver, Shanghai and Jakarta, Bolt Metals is well positioned to leverage Asia’s global dominance in the battery manufacturing sector.”

Indonesia’s commitment extends to the very top of government, with Joko Widodo – Indonesia’s President – stating in September 2019 that “for nickel, we want raw materials to be processed in Indonesia. We want added values”. This supports previous pronouncements from key officials, including Indonesian Maritime Minister, Luhut Pandjaitan who remarked that Indonesia will “become the main player in lithium batteries” and that it will “control the world market”.

The country, which is the world’s top nickel ore exporter, has stopped export of unprocessed nickel ore to support this plan.

During 2019 the Company carried out an extensive exploration and development program on Cyclops and achieved successful nickel results with its drilling and bench-scale scoping tests for processing of materials.

Drilling identified significant horizons of nickel mineralization and bench-scale scoping tests returned positive results for processing of this nickel rich material.

The recovery percentages form the bench-scale test program are set out below (for further information, please refer to the Company’s press release of October 28, 2019):

Sample Nickel (%) Cobalt (%) Iron (%)
Limonite 99.26 98.82 97.77
Low Iron Transition 99.75 97.03 99.22
Saprolite 99.77 >99.9 99.74

 

Selected elevated nickel drill results are provided below from the Company’s shallow drilling program (for further information, please refer to the Company’s press releases of March 5, April 1, April 23, June 13, June 20 and September 10, 2019):

Intersection length (metres from surface) Nickel (%) Cobalt (%)
7.0 2.15% 0.03%
4.0 1.96% 0.04%
2.0 2.00% 0.01%
2.0 1.91% 0.05%

 

2020 will see continued and consistent development in Pacific Rim Cobalt’s strategy as the company continues to set ambitious milestones with the goal of becoming a leading international player in the EV battery metal sector and creating significant long-term shareholder value.

This includes preparations to commission and operate the company’s pilot plant in Canada, which will contain an integrated circuit to produce high-purity nickel and cobalt strip solutions to develop battery-grade nickel and cobalt.

The results of the pilot plant will then be used to establish the design criteria for the subsequent demonstration plant in Indonesia, which will produce nickel and cobalt products suitable to meet market specifications. As well as demonstrating Pacific Rim Cobalt’s ability to produce a product within market specifications, this will also be used to establish the design criteria for the company’s commercial-scale plant.

Pacific Rim Cobalt’s world-class management team includes Ranjeet Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.

Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.

Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.

Bolt Metals Corp. (OTCQB: PCRCF), closed Wednesday's trading session at $0.2125, up 14.8649%, on 28,910 volume with 19 trades. The average volume for the last 3 months is 34,939 and the stock's 52-week low/high is $0.079999998/$0.259299993.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Diversified holding company SinglePoint’s (OTCQB: SING) 1606 Original Hemp Cigarette brand has been amassing substantial sales online. An article further discussing the company’s hemp brand reads, “On the hemp front, SinglePoint’s 1606 Original Hemp line features a filtered, pre-rolled, 100% tobacco- and nicotine-free hemp cigarette. To view the full article, visit http://cnw.fm/ldO5A.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Wednesday's trading session at $0.0097, up 6.5934%, on 1,048,331 volume with 60 trades. The average volume for the last 3 months is 4,218,277 and the stock's 52-week low/high is $0.007/$0.021999999.

Recent News

chart

Predictive Oncology (NASDAQ: POAI)

The QualityStocks Daily Newsletter would like to spotlight Predictive Oncology (POAI).

Precision medicine and artificial intelligence rank high on the list of top investment-focused healthcare trends, according to a recent Emagine article (http://nnw.fm/jKVt0). Both are key areas of focus for Predictive Oncology Inc. (NASDAQ: POAI), a leading data and artificial-intelligence-driven precision medicine company. In an arena where data is king and artificial intelligence is increasingly gravitating to the spotlight, POAI is uniquely positioned with its historic database of patient samples and its cutting-edge AI-powered platform.

Predictive Oncology (POAI) is a knowledge-driven precision medicine company focused on applying data and artificial intelligence (AI) to personalized medicine and drug discovery. The company applies its smart tumor profiling and AI platform to extensive genomic and biomarker patient data sets to build predictive models of tumor drug response to improve clinical outcomes for the cancer patients of today and tomorrow. The company has several tools that support its mission of bringing precision medicine to the treatment of cancer.

Through its subsidiaries, Predictive Oncology’s portfolio of assets includes the following:

  • A database of clinically validated historical and outcome data from patient tumors
  • An in-house Clinical Laboratory Improvement Amendments (CLIA)-certified lab
  • A “smart” patient-derived tumor profiling platform
  • An in-house bioinformatics artificial intelligence (AI) platform
  • A new computerized approach growing tumors in the lab to rapidly develop patient specific treatment options
  • An FDA-approved fluid collection and disposal system

Using these resources, and in collaboration with key players in the pharmaceutical, diagnostic and biotech industries Predictive Oncology is working to determine the best pathways for more individualized and effective cancer treatment.

Subsidiaries

Predictive Oncology leverages the synergies of its three wholly owned subsidiaries to bring precision medicine to the diagnosis of cancer.

Helomics applies artificial intelligence to its rich data gathered from the company’s trove of more than 150,000 tumors to personalize cancer therapies for patients as well as drive the development of new targeted therapies in collaborations with pharmaceutical companies. This database, the largest of its kind in the world, is comprised of ovarian, head and neck, colon and pancreas tumors. Helomic’s CLIA-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions, by providing an evidence-based roadmap for therapy.

In addition to its proprietary precision oncology platform, Helomics offers boutique CRO services that leverage its TruTumor™ patient-derived tumor models coupled to a wide range of multi-omics assays (genomics, proteomics and biochemical), and an AI-powered proprietary platform (D-CHIP) to provide a tailored solution to its clients’ specific needs.

TumorGenesis is developing a new, rapid approach to growing tumors in the laboratory without the use of rats or mice, allowing for the identification of biomarkers indicative of cancer. This methodology “fools” the tumor into thinking it is still in the body. As a result, the tumor reacts as it naturally would, thereby increasing the accuracy of the biomarker. Once the biomarkers are identified, they can be used in TumorGenesis’ Oncology Capture Technology Platforms which isolate and helps categorize an individual patient’s heterogeneous tumor samples to enable development of patient-specific treatment options.

Skyline Medical’s patented, FDA-cleared STREAMWAY® System is the first true, direct-to-drain fluid disposal system designed specifically for medical applications such as radiology, endoscopy, urology and cystoscopy procedures. The STREAMWAY system is changing the way healthcare facilities collect and dispose of potentially infectious waste fluid by connecting directly to a facility’s plumbing system to automate the collection, measurement and disposal of waste fluids.

The STREAMWAY minimizes human intervention for better safety and improves compliance with Occupational Safety and Health Administration (OSHA) and other regulatory agency safety guidelines. The STREAMWAY eliminates canisters, carts and evacuated bottles, which reduces overhead costs and minimizes environmental impact by helping to eliminate the approximately 50 million potentially disease-infected canisters that go into landfills annually in the United Sates.

Skyline has achieved sales in five of the seven continents through both direct sales and distributor partners.

Competitive Advantage

Precision medicine has become the holy grail of cancer therapeutics. Data driven predictive models of tumors and their responses are critical in both new drug development and individualized patient treatment. The race has begun to model various tumors, which takes 5 to 7 years of clinical evaluation to establish historical and outcome data.

Predictive Oncology enjoys significant competitive advantage. The company already has a vast historical collection of tumors and related data, plus the ability to obtain existing associated outcome data. While others wait for outcome data, Predictive Oncology is in a unique and powerful position, working to deliver the promise of precision medicine to reality. Predictive Oncology already has the clinical data, including how a tumor responded to certain drugs, an in-house bioinformatics AI platform, and only needs to do the tumor sequencing. The significance is underscored by the collaboration with UPMC Magee-Women’s Hospital, designed to reveal which mutations responded to which drug then develop powerful predictive models for future testing and treatment.

Leadership Team

Dr. Carl Schwartz was appointed to Skyline Medical’s board of directors in March 2015 and became interim president and CEO in May 2016. Dr. Schwartz became CEO of Plastics Research Corporation in 1988, leading the company to become the largest manufacturer of structural foam molding products in the U.S. with more than $60 million in revenues and 300 employees by the time he retired in 2001. He holds a bachelor’s degree and DDS degree from the University of Detroit.

CFO Bob Myers has over 30 years of experience in multiple industries focusing on medical device service and manufacturing. He has spent much of his career as a CFO and controller. Myers holds an MBA in Finance from Adelphi University and a BBA in public accounting from Hofstra University.

Gerald Vardzel, President of Helomics, has over 25 years of healthcare executive management experience developing and implementing commercialization strategies and models for technology launches. His Go-To-Market expertise includes equity financing, strategic planning, market intelligence, M&A, and new market development in both start-up and established settings including fortune 500 market leaders. He has developed innovative solutions for both CLIA and FDA regulatory paths defining the delivery chains from discovery to clinical acceptance. Mr. Vardzel also has significant experience designing and implementing sales and marketing programs tailored not only to expand market share, but to empirically assess client satisfaction, strengthen business processes, and maximize profitability. Mr. Vardzel was previously Vice President of Corporate Development and Strategic Initiatives at Global Specimen Solutions. Furthermore, as an executive affiliate to the healthcare industry, he routinely consults for several small-to-mid sized private equity firms advising on, in part, the feasibility of acquisition targets. Mr. Vardzel graduated from the University of Pittsburgh.

Dr. Mark Collins, Chief Information Officer of Helomics, has held multiple executive roles in a variety of discovery, informatics and bioinformatics functions within global pharma, and founded three startup software companies in the machine learning and drug discovery space. In 2001, Dr. Collins worked for Cellomics (now part of Thermo Fisher Scientific), where he played a pivotal role in establishing the High-Content Cell Analysis market, building and commercializing several key informatics and bioinformatics products. After leaving Thermo Fisher, Dr. Collins developed and commercialized informatics solutions for clinical and translational research, specifically in the specimen tracking, omics data management and NGS analysis space, through key roles at BioFortis, Global Specimens Solutions and Genedata. Dr. Collins received his undergraduate degree in Applied Science from the University of Wolverhampton, UK and his Ph.D. in Microbiology from the University of Surrey, UK.

Predictive Oncology (POAI), closed Wednesday's trading session at $2.28, off by 2.9787%, on 41,448 volume with 225 trades. The average volume for the last 3 months is 151,434 and the stock's 52-week low/high is $1.96000003/$8.50.

Recent News

chart

InsuraGuest Inc. (TSX.V: ISGI)

The QualityStocks Daily Newsletter would like to spotlight InsuraGuest Inc. (TSX.V: ISGI).

InsuraGuest Technologies (TSX.V: ISGI) is the developer of a proprietary InsurTech platform designed to deliver insurance products to the hotel and vacation-rental market. To view the full article, visit http://nnw.fm/o0MIl.

InsuraGuest Inc. (TSX.V: ISGI) is a SaaS (Software-as-a-Service) company utilizing its proprietary flagship InsurTech software platform to provide specialized insurance products to end users in the business-to-business (B2B) and business-to-consumer (B2C) markets. The company’s first focus is on the B2B hotels and vacation rentals sectors, where its API integrates with the clients’ property management systems to offer guests a specialized guest protection policy. The platform and policy combination “InsurTech” product helps transfer the exposure to liability away from the client/property while guests benefit from potential accident and loss coverage during their stay.

InsuraGuest’s platform is currently capable of integrating with approximately 70 different hotel and vacation rental property management systems, giving it access to roughly 40,000 properties worldwide.

The company continues to pursue expansion opportunities and recently signed a Letter of Intent with a master general agent in the United Kingdom and Europe to distribute its platform and products to hotel and vacation rental markets in those regions. The company also has plans to expand to Asia in 2020.

Protecting Guests, Enhancing Customer Experience

InsuraGuest is the first line of defense for both the property and the guest.

InsuraGuest is purchased by the hotel or vacation rental “property,” which offers the policy to each registered guest and its occupants for an additional fee. The specialized policy affords coverage for theft of personal property while in the hotel, as well as accidental medical expense and accidental death and dismemberment, up to the policy limits of $2,500 to $50,000.

Market Opportunity

The U.S. hotel industry generated more than $218 billion in annual revenues in 2018, an increase of $10 billion from the previous year, according to STR’s 2019 HOST Almanac. The European market is more than double the size of the U.S. market. According to Oxford Economics, there were 6.4 billion nights stayed in the world, with 2.6 billion hotel nights stayed in Asia, 2.8 billion nights stayed in Europe, and 1.1 billion stayed nights in the United States. Additionally, $100 billion was spent on vacation rentals in the United States, where there approximately 4.5 million second homes are being managed by a third-party rental company.

With distribution in Europe and the United States, InsuraGuest’s combined demographics will total 3.9 billion nights stayed, and will more than double its vacation rental opportunities.

Within this burgeoning, high-demand industry is risk of liability to guest injury. For example, gym injuries are among the top five most common hotel accidents. Without proper hedges in place, the property may be liable in a personal injury claim or lawsuit.

Though the potential for accidents, slip and falls and mishaps can be widespread, it can be covered under the InsuraGuest Specialized Guest Protection Policy to provide guests a worry-free and enjoyable stay that potentially increases loyalty for the property.

Business Highlights

  • Targeting hotels and vacation rentals, a multi-billion-dollar industry
  • Providing the first line of defense in case of accident, loss or death
  • Expanding distribution reach with footing in European hotel and vacation rental markets
  • Expansion into Asia by 2020

Executive Team

Douglas Anderson, Chairman & Chief Executive Officer
Douglas Anderson has been a businessman in the real estate industry for nearly 30 years. His business expertise includes master planning and development implementation for larger-scale resorts, business parks and commercial developments across the USA and two provinces in Canada. His business endeavors include the founding of the 7th larger private equity fund in America focusing on multifamily and senior care (ROC Fund/Bridge IPG Fund). He serves as chairman/founder of a golf and winter sports ski holding company with operations in four major east coast markets and British Columbia, Canada.

Anderson earned a BS undergraduate degree in Consumer Studies with an emphasis in Architecture as an undergraduate at the University of Utah. He subsequently earned his Master’s in Business Administration. He also attended a three-year OPM Program a postgraduate business education at Harvard Business School in Boston. Anderson is an avid skier and outdoor enthusiast.

Charles James Cayias, President & Director
Charles James Cayias is also the president and owner of Charles James Cayias Insurance Inc. He is a third-generation insurance professional whose creativity and artistic vision have enabled him to establish a full-service agency combined with the personal service each client deserves. His outstanding people skills, honesty, integrity and fairness are evident by his loyal and growing clientele, the majority of which are referrals who become long-time customers and friends.

Cayias began his insurance career in the early 1970s and has been licensed since 1977. He is licensed in all 50 states and specializes in niche programs. He has extensive expertise in all aspects of the insurance industry including commercial insurance, employee benefits, workers’ compensation, professional liability, risk management and bonding.

Christopher J. Panos, Vice President & Director
Christopher J. Panos is a highly competitive sales professional with over 15 years of territory manager sales experience and an award-winning record of achievements. He is exceptionally well organized with a proven work history that demonstrates self-discipline, superb communication skills, and the initiative to achieve both personal and corporate goals. Panos is successful in building relationships with a large network of industry professionals in order to grow and maintain new and existing business, exceed new sales objectives and provide in-depth product training to authorized dealers and sales personnel.

Alexander Walker III ESQ, Corporate Counsel & Director
Alexander Walker III ESQ has served as director of the company since September of 2018. He also has served as counsel to the company since July of 2018. Walker is an attorney and has been a member of the Utah Bar Association since 1987 and a member of the Nevada State Bar since 2003. His practice has involved general business litigation, in both federal and state courts, and transactional work, including securities offerings and registration, corporate formation and periodic reporting compliance. Walker has provided legal services to emerging businesses throughout his carrier and at times has served as an officer and board member as well as legal counsel public companies. His duties as legal counsel for a public company engaged in the business of ownership and operation of coal-producing properties in the western United States included oversight of corporate-related legal matters including securities reporting, corporate compliance, federal and state mining regulation, and employment law oversight. He also has served as the chair of the Mining Committee of the Energy, Natural Resources and Environmental Law Section of the Utah State Bar, a member of the board of directors of the South East Utah Energy Producers Association, the co-chair of the board of the Western Energy Training Center, a board member of the Utah Supreme Court Committee to Review the ABA Recommendations Regarding the Office of Professional Conduct, and a board member of the University of Utah Crimson Club.

Roger Bloss, Corporate Consultant & Board Advisor
Roger Bloss joined InsuraGuest in August of 2019 to advise the company and its board on hotel transactions, contributing his knowledge from more than 40 years in the hospitality industry. Bloss previously served in executive positions with several major hotel franchise companies and in 1996 founded Vantage Hospitality Group hotel brands. Under his leadership, Vantage became a Top 10 global hotel company and made the Inc. 500/5000 list of Americas’ fastest-growing private companies for eight straight years. Bloss was named Lodging Magazine’s “Innovator of the Year” in 2006 and 2010, and in 2009 earned a spot on HSMAI’s “Top 25 Extraordinary Minds in Sales and Marketing.” Bloss joined Red Lion Hotels Corporation (RLHC) in September 2016 in conjunction with the acquisition of Vantage.

InsuraGuest Inc. (TSX.V: ISGI), closed Wednesday's trading session at $0.25, off by 26.47, on 230,750 volume with 29 trades. The average volume for the last 3 months is 3,721 and the stock's 52-week low/high is $0.07/$0.100000001.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, this morning announced that the company’s chairman and chief executive officer Rodney Varner will be leading a presentation and answering questions from investors at the third annual LD Micro Virtual Conference. To access the live presentation, visit http://nnw.fm/9Ny2z. To view the full press release, visit http://nnw.fm/Vo7V8.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Wednesday's trading session at $4.52, up 2.0316%, on 2,132,464 volume with 5,634 trades. The average volume for the last 3 months is 7,476,311 and the stock's 52-week low/high is $0.231000006/$7.0300002.

Recent News

chart

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) was highlighted today in a publication from MarijuanaStocks.com, examining how, over the past few years, we have seen a growing amount of interest from pot stock investors. This interset has led investors into the ultra-premium cannabis niche. These companies focus on producing small batches of extremely high-quality marijuana.

Supreme Cannabis Company Inc. (TSX: FIRE) (OTC: SPRWF) is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees and culture of innovation. The company aims to grow the world’s best legal cannabis and become a leader in the global industry. Supreme Cannabis calls its Toronto Venture Exchange stock symbol, “FIRE,” a testament to the company’s passion for cannabis and obsession with quality.

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as one of Canada’s most premium cannabis producers, the company sees itself at the center of this global shift.

A key piece of Supreme Cannabis’ ability to fulfill its mission is its flagship brand, 7ACRES, a wholly owned subsidiary that operates a 440,000-square-foot hybrid cultivation facility in Kincardine, Ontario. 7ACRES is focused on building a core competency in scaled high-quality cannabis production. With a best-in-class cultivation facility producing a competitive product that fuels a leading premium brand, Supreme Cannabis has achieved a differentiated advantage in cultivation IP, products and branding. The company’s foundational investment in premium cultivation has secured it a leadership position in the industry as the Canadian market becomes more competitive and matures.

Since legalization, 7ACRES has brought five premium flower strains to market in Canada. The demand for 7ACRES product continues with the company’s most recent launch of Jack Haze, a new proprietary premium cultivar. The company’s first sativa-dominant strain, Jack Haze offers rare sensory characteristics, delivering high THC content with a terpinolene forward profile, including a complex aroma with notes of citrus, pine and warm spice. As it develops its next winning strain, 7ACRES continues to prioritize subjective quality. In the Canadian cannabis market, this approach has established 7ACRES as a well-known premium brand that commands premium pricing coast-to-coast.

In addition to 7ACRES, Supreme Cannabis has built a diversified portfolio of focused consumer-driven brands:

  • Sugarleaf by 7AC – this new brand widens Supreme Cannabis’ product offerings and targets consumers who are looking for more refined, milder consumption experience as they discover their own cannabis taste preferences and desires. Product formats under this brand are focused on offering consumers elegant and convenient cannabis experiences.
  • Blissco — dedicated to providing wellness focused consumers with premium cannabis products, education, and outstanding customer care. Blissco is focused on bringing its collection of premium whole-flower CBD oils to market.
  • Truverra — focused on being a global leader in the development, production and marketing of hemp and cannabis-derived medicinal products with clinically proven efficacy. With over 25 SKUs sold online in the UK and Europe, Truverra is ideally positioned to address emerging international cannabis opportunities.
  • Khalifa Kush Enterprises — formed through a prestigious international partnership with Khalifa Kush Enterprises (KKE) Canada, the Canadian counterpart to the popular U.S. cannabis brand KKE formed by Wiz Khalifa. Together, Supreme Cannabis and KKE Canada are developing and launching a lineup of premium cannabis products, including a future line based on the well-known Khalifa Kush strain.

Each of Supreme Cannabs’ brands and partnerships have been strategically identified and designed to support the company’s mission to enhance the lives of consumers through positive cannabis experiences. Equally important to delivering desirable consumer experiences is the infrastructure supporting the company’s brands and products. From seed to sale, supreme cannabis continues to build an impressive group of operating assets that serve key functions throughout the value chain:

  • Cultivation – for starters, there is Supreme Cannabis’ foundational flagship asset, its 440,000-square-foot cultivation facility in Kincardine, Ontario. With over 600 employees, 24 grow rooms, and best-in-class processing equipment and procedures, this facility is expected to reach an annual production capacity of 50,000 kilograms in the near-term. In this purpose-built facility, the company grows small-batch high-quality cannabis from 10,000-square-foot grow rooms and completes a proprietary hang-dry for up to two weeks.
  • Extraction – with the acquisition of Blissco in fiscal 2019, in addition to the Blissco wellness brand, Supreme Cannabis gained a 12,000-square-foot dedicated extraction facility in Langley, BC. This facility conducts both C02 and ethanol extraction and with the recent receipt of its oil sales license from Health Canada, it now produces Blissco branded CBD oils and expects to fill vaporizer pods for a partnership between the company’s 7ACRES brand and Pax Labs.
  • Manufacturing – most recently, the company announced its 107,000-square-foot processing, packaging and manufacturing facility in Kitchener, naming the facility Supreme Cannabis Kitchener. In Q4 FY2020, the company expects to begin whole flower packaging and pre-roll manufacturing for Supreme Cannabis brands at the Kitchener Facility. In the long-term, in additional to processing its own inputs, Supreme Cannabis intends generate incremental revenue by packaging, distributing and branding third-party cannabis inputs from quality-focused cultivators.
  • R&D and Product Testing – In Q1 FY2020, Supreme Cannabis closed the acquisition of Truverra and acquired a 5,000-square-foot facility licensed under Canadian Clinical Cannabinoids Inc. in Scarborough, Ontario (“Supreme Cannabis Scarborough”). Supreme Cannabis Scarborough provides R&D space for the company to test new products and develop medicinal science intellectual property. In the near-term, with the legalization of 2.0 cannabis products, this centre for innovation will be testing and bringing concentrate products to market under the 7ACRES brand.

Supreme is committed to continue to identify new opportunities to grow and strengthen its impressive portfolio of operating assets and brands and scale its strong Canadian business globally.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed Wednesday's trading session at $0.2339, up 6.3182%, on 262,711 volume with 182 trades. The average volume for the last 3 months is 470,500 and the stock's 52-week low/high is $0.197400003/$1.75.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD) today announced a dramatic 300% sequential monthly jump in delivery volume in BudCars Cannabis Delivery Service in February. According to the update, the rise in volume follows the company’s negotiated agreement toward a controlling stake in Budcars and its investment in expanding the leading delivery service’s operations and reach in Northern California. To view the full press release, visit http://cnw.fm/EnMC8.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Wednesday's trading session at $0.0045, up 28.5714%, on 91,237,281 volume with 926 trades. The average volume for the last 3 months is 6,394,219 and the stock's 52-week low/high is $0.0023/$0.061.

Recent News

chart

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF).

HTC Extraction Systems (TSXV:HTC) (OTC:HTPRF) is pleased to announce the hiring of their North America, Director of Sales, Joel Taylor, for their wholly owned subsidiary, Kase Farma Inc. ("Kase Farma"), in Ceres, California. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. On Friday afternoon, the Florida Senate filed a proposal whose aim is to put a limit on the amount of THC available in medical marijuana products. The potency cap would be at 10%.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (OTCQB: HTPRF), closed Wednesday's trading session at $0.07825, even for the day, on 200 volume. The average volume for the last 3 months is 245 and the stock's 52-week low/high is $0.078249998/$0.920000016.

Recent News

chart

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)

The QualityStocks Daily Newsletter would like to spotlight Wonderfilm Media Corporation (OTC: WDRFF).

The Wonderfilm Media Corporation (TSXV: WNDR) (OTCQB: WDRFF) is pleased to announce that it has filed its audited annual consolidated financial statements, management's discussion and analysis and associated officer certificates for Wonderfilm's financial year ended June 30, 2019, the interim financial statements, management's discussion and analysis and associated officer certificates for the Company's three (3) month period ended September 30, 2019, and the interim financial statements, management's discussion and analysis and associated officer certificates for the Company's three (3) and six (6) month periods ended December 31, 2019, all of which are available under the Company's profile on SEDAR at www.sedar.com.

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.

Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.

Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.

The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.

Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.

Management Team with Proven Track Records

Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.

Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.

Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.

Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.

Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.

17-Title Movie Slate — Greenlit

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.

Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.

The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.

 

Potential for Breakout Success

Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.

Note: Potential breakout films are not factored into company’s revenue projections.

Base Hits and Home Runs

In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.

Recent Industry Breakout Films Include:

  • SAW – $1.2 million budget = $103.9 million in sales
  • Pulp Fiction – $8 million budget = $212 million in sales
  • My Big Fat Greek Wedding – $5 million budget = $250 million in sales
  • Lost in Translation – $4 million budget = $120 million in sales
  • Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)

Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.

Recent Wonderfilm Releases

  • Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
  • Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
  • Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
  • Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.

Wonderfilm Global Distribution

At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.

Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.

The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.

A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.

Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.

Wonderfilm Business Model

Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.

Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.

Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.

Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.

Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.

Sales overages once contracted presale threshold is surpassed.

The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.

Note: The nature of the film business is that box office revenue lags production up to a couple of years.

$50 Million Wonderfilm Production Fund (WPF):

Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.

The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.

For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.

All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.

Wonderfilm Media Corporation (OTC: WDRFF), closed Wednesday's trading session at $0.075, off by 25.5583%, on 500 volume with 1 trade. The average volume for the last 3 months is 37,982 and the stock's 52-week low/high is $0.072099998/$0.270220011.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed Wednesday's trading session at $0.6143, up 15.9057%, on 56,693 volume with 23 trades. The average volume for the last 3 months is 46,966 and the stock's 52-week low/high is $0.409999996/$4.75.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.